secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2024-01-18T23:59:59+00:00
Accession:  0000950170-24-005186
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heart Test Labs shareholders approve reverse stock split and name change to HeartSciences; quorum item adjourned
--------------------------------------------------------------------------------

- 54.37% of shares present at Jan 17 annual meeting; all Class I and II director nominees re-elected.
- Shareholders approved reverse stock split in range 1:2 to 1:100 at Board's discretion.
- Corporate name change from 'Heart Test Laboratories, Inc.' to 'HeartSciences Inc.' approved.
- Proposal 7 to reduce quorum to one-third failed to get sufficient votes; meeting adjourned to Feb 15, 2024 for additional solicitation.
- Proposals on ELOC share issuance and 2023 Equity Incentive Plan also approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000095017024005186/0000950170-24-005186-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000095017024005186/hscs-20240117.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-005186

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer